)
)
Akero Therapeutics Investor Relations Material
Latest events
Study Result
Akero Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Akero Therapeutics Inc
Access all reports
Akero Therapeutics Inc. is a clinical-stage biopharmaceutical company primarily engaged in developing innovative treatments for serious metabolic diseases with significant unmet medical needs. The company's primary focus is on its lead product candidate, efruxifermin (EFX), which is in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH), a progressive liver disease characterized by fat accumulation and inflammation in the liver. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
)
Ramon Laguarta: PepsiCo's Veteran Chairman and CEO
Ramon Laguarta, CEO and Chairman of the food and beverage giant PepsiCo leads its global expansion and transition toward a more sustainable future.
10 Mar 2025
)
Rise of the Clog: The Unexpected Success of Crocs
Crocs has created a unique position in the shoe market with an eye-catching design and marketing strategy involving several successful collaborations.
7 Mar 2025
Ticker symbol
AKRO
Country
🇺🇸 United States